$16.2MSeries B, 7 November 2025
Series B to expand US commercial presence, product innovation and clinical informatics.
- Amount
- $16.2M
- Stage
- Series B
- Announced
- 7 November 2025
- Lead
- Aviron Investment Management
- Other investors
- Oncology Ventures
- Use of funds
- Series B to expand US commercial presence, product innovation and clinical informatics.
- Checked
- Amount and date checked against the press source
- Source
- Lumonus AI raises A$25M smartcompany.com.au